An interventional study of Motec total wrist arthroplasty and Remotion total wrist arthroplasty in Non-rheumatoid Wrist Arthritis, sponsored by Oslo University Hospital. Active, not recruiting at 1 site in Norway. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2024-02-28.
Sponsored by Oslo University Hospital · Not applicable, Interventional, and Treatment
The purpose of this study is to determine the difference in the results between Motec and Remotion wrist arthroplasty in the treatment of non-rheumatoid wrist arthritis.
3,554 studies on the registry are indexed under Arthritis; 317 are open to participants now.
This study's enrollment of 40 is below the median of 90 across 2,377 interventional studies indexed under Arthritis.
Browse Arthritis studies →Oslo University Hospital is the lead sponsor of 810 studies on the registry; 148 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria:
Procedure: Motec total wrist arthroplasty
Procedure: Remotion total wrist arthroplasty
PRWHE (Patient rated Wrist and Hand Evaluation score)
PRWHE is a wrist specific patient assessed questionnaire, measuring pain, wrist specific function and general function
Time frame: 24 months postop
Wrist movement
Overall degree of flexion, extension, radial and ulnar deviation
Time frame: 24 months postop
Grip Strength
Time frame: 24 months postop
Pain in affected wrist
Visual analogue scale
Time frame: 24 months postop
Quick-DASH
"Disabilities of the Arm, Shoulder and Hand" questionnaire
Time frame: 24 months postop
intraoperative complications
Time frame: intraoperative
Postoperative complications
Time frame: 24 months postop
Implant loosening
Implant loosening seen on x-ray
Time frame: 24 months postop
Implant migration
Implant migration seen on model-based roentgen stereophotogrammetric analysis (RSA), as a possible precursor of later implant loosening
Time frame: 24 months postop
Periprosthetic bone mineral density
BMD measured with DEXA (dual-energy x-ray absorptiometry)
Time frame: 24 months postop
Reoperations
Reoperations of any cause
Time frame: 24 months postop
This study is active, not recruiting, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Oslo University Hospital